Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. University Hospital Hradec Králové

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The University Hospital Hradec Králové is a major academic medical center in the Czech Republic, affiliated with Charles University Faculty of Medicine in Hradec Králové. Located in Hradec Králové, the hospital plays a key role in providing advanced healthcare, supporting medical education, and conducting scientific research. The hospital offers a wide range of specialized services, including internal medicine, surgery, oncology, cardiology, neurology, and intensive care. It is equipped with modern diagnostic and therapeutic technologies, allowing it to manage complex and multidisciplinary cases. The institution is also recognized for its expertise in trauma care, transplantation, and specialized surgical procedures. In addition to patient care, the hospital is actively involved in clinical research and international collaborations, contributing to advancements in medical science. As a teaching hospital, it provides practical training for medical students and healthcare…

Source: Trial-derived.
45Total Trials
Source: Trial-derived.
4Recruiting Trials
Source: Trial-derived.
17Active Trials
Source: Trial-derived.
21Completed Trials
Source: Trial-derived.
53Unique Conditions
Source: Trial-derived.
51Unique Sponsors

Conditions

Source: Trial-derived. Diffuse Large B-Cell Lymphoma (3)Source: Trial-derived. Acute Myeloid Leukemia (AML) (2)Source: Trial-derived. Carcinoma, Renal Cell (2)Source: Trial-derived. Hodgkin Lymphoma (2)Source: Trial-derived. Severe Hypertriglyceridemia (2)Source: Trial-derived. Advanced Melanoma (1)Source: Trial-derived. Advanced Solid Tumor (1)Source: Trial-derived. Alzheimer's Disease (1)

Sponsors

Source: Trial-derived. AbbVie (7)Source: Trial-derived. Merck Sharp & Dohme LLC (6)Source: Trial-derived. Seagen Inc. (5)Source: Trial-derived. Genmab (4)Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. University Hospital Hradec Kralove (3)Source: Trial-derived. Bristol-Myers Squibb (2)Source: Trial-derived. Kowa Research Institute, Inc. (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. PET-CT

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Minimal residual disease (MRD) testing